Global Blood Therapeutics Tops Q1 EPS by 4c

  • Investing.com
Global Blood Therapeutics Tops Q1 EPS by 4c

Global Blood Therapeutics (NASDAQ: GBT ) reported Q1 EPS of ($1.26), $0.04 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $55.16 million versus the consensus estimate of $56.14 million.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles